These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8071686

  • 21. Rhenium-188-HEDP in the palliative treatment of bone metastases.
    Liepe K, Hliscs R, Kropp J, Grüning T, Runge R, Koch R, Knapp FF, Franke WG.
    Cancer Biother Radiopharm; 2000 Jun; 15(3):261-5. PubMed ID: 10941533
    [Abstract] [Full Text] [Related]

  • 22. Application of rhenium-188 HEDP in bone metastases therapy.
    Scheffler J, Derejko M, Bandurski T, Romanowicz G.
    Nucl Med Rev Cent East Eur; 2003 Jun; 6(1):55-7. PubMed ID: 14600935
    [Abstract] [Full Text] [Related]

  • 23. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
    Leondi AH, Souvatzoglou MA, Rapti AS, Leontopoulou SA, Papadaki EK, Datseris EI, Anagnostopoulou US, Zerva CJ.
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
    [Abstract] [Full Text] [Related]

  • 24. Systemic radionuclide therapy in pain palliation.
    Liepe K, Runge R, Kotzerke J.
    Am J Hosp Palliat Care; 2005 Sep; 22(6):457-64. PubMed ID: 16323716
    [Abstract] [Full Text] [Related]

  • 25. The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study.
    Han SH, de Klerk JM, Tan S, van het Schip AD, Derksen BH, van Dijk A, Kruitwagen CL, Blijham GH, van Rijk PP, Zonnenberg BA.
    J Nucl Med; 2002 Sep; 43(9):1150-6. PubMed ID: 12215552
    [Abstract] [Full Text] [Related]

  • 26. 186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases.
    Han SH, De Klerk JM, Zonnenberg BA, Tan S, Van Rijk PP.
    Q J Nucl Med; 2001 Mar; 45(1):84-90. PubMed ID: 11456380
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy.
    Colnot DR, Wilhelm AJ, Cloos J, Roos JC, de Bree R, Quak JJ, Snow GB, van Dongen GA.
    J Nucl Med; 2001 Sep; 42(9):1364-7. PubMed ID: 11535726
    [Abstract] [Full Text] [Related]

  • 28. Rhenium-188(Sn)HEDP for treatment of osseous metastases.
    Maxon HR, Schroder LE, Washburn LC, Thomas SR, Samaratunga RC, Biniakiewicz D, Moulton JS, Cummings D, Ehrhardt GJ, Morris V.
    J Nucl Med; 1998 Apr; 39(4):659-63. PubMed ID: 9544677
    [Abstract] [Full Text] [Related]

  • 29. Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer.
    van der Poel HG, Antonini N, Hoefnagel CA, Horenblas S, Valdes Olmos RA.
    Urol Int; 2006 Apr; 77(1):50-6. PubMed ID: 16825816
    [Abstract] [Full Text] [Related]

  • 30. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Liepe K, Franke WG, Kropp J, Koch R, Runge R, Hliscs R.
    Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
    [Abstract] [Full Text] [Related]

  • 31. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases.
    Palmedo H, Guhlke S, Bender H, Sartor J, Schoeneich G, Risse J, Grünwald F, Knapp FF, Biersack HJ.
    Eur J Nucl Med; 2000 Feb; 27(2):123-30. PubMed ID: 10755716
    [Abstract] [Full Text] [Related]

  • 32. [Pain therapy with rhenium-186 HEDP in multiple bone metastases].
    Palmedo H, Bender H, Schomburg A, Grünwald F, Schöneich G, Zamorra P, Reichmann K, Dierke-Dzierzon C, Mallmann P, Biersack HJ.
    Nuklearmedizin; 1996 Apr; 35(2):63-7. PubMed ID: 8721578
    [Abstract] [Full Text] [Related]

  • 33. A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.
    Buffa FM, Flux GD, Guy MJ, O'Sullivan JM, McCready VR, Chittenden SJ, Dearnaley DP.
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1114-24. PubMed ID: 12761596
    [Abstract] [Full Text] [Related]

  • 34. Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
    Pirayesh E, Amoui M, Mirzaee HR, Tabei F, Rakhsha A, Kalantari BA, Shafiei B, Assadi M, Asli IN.
    J Nucl Med Technol; 2013 Sep; 41(3):192-6. PubMed ID: 23918612
    [Abstract] [Full Text] [Related]

  • 35. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
    Liepe K, Kropp J, Hliscs R, Franke WG.
    Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
    [Abstract] [Full Text] [Related]

  • 36. Marrow toxicity and radiation absorbed dose estimates from rhenium-186-labeled monoclonal antibody.
    Breitz HB, Fisher DR, Wessels BW.
    J Nucl Med; 1998 Oct; 39(10):1746-51. PubMed ID: 9776281
    [Abstract] [Full Text] [Related]

  • 37. Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases.
    Palmedo H, Bender H, Dierke-Dzierzon C, Carl UM, Risse J, Krebs D, Biersack HJ.
    Clin Nucl Med; 1999 Sep; 24(9):643-8. PubMed ID: 10478737
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases.
    Sciuto R, Tofani A, Festa A, Giannarelli D, Pasqualoni R, Maini CL.
    J Nucl Med; 2000 Apr; 41(4):647-54. PubMed ID: 10768566
    [Abstract] [Full Text] [Related]

  • 40. Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.
    Maxon HR, Schroder LE, Thomas SR, Hertzberg VS, Deutsch EA, Scher HI, Samaratunga RC, Libson KF, Williams CC, Moulton JS.
    Radiology; 1990 Jul; 176(1):155-9. PubMed ID: 1693784
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.